Abstract
The activity of inflammatory bowel disease (IBD) is often difficult to monitor by currently available laboratory tests. The oxidative metabolic activity of Ficoll-Hypaque separated human neutrophils was determined in a luminol-dependent chemiluminescence assay and compared to the white blood cell (WBC) count and the erythrocyte sedimentation rate (ESR) among 13 subjects with inflammatory bowel disease. Clinical disease activity was assessed with a standardized scoring system and judged to be mild in five subjects and absent (remission) in the other eight subjects. The chemiluminescent response of neutrophils was increased among 12 persons compared to that of healthy subjects. In contrast, the WBC count and ESR were abnormal only among two and four individuals, respectively. The widespread abnormality in neutrophil chemiluminescence, even among subjects classified as being in remission, suggests that chemiluminescence determinations may provide a means to monitor longitudinal changes in disease activity.
Similar content being viewed by others
References
Summers RW, Switz DM, Sessions JT, Bectel JM, Best WR, Kern F, Singleton JW: National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 77:847–869, 1979
Kirsner JB: Observations on the medical treatment of inflammatory bowel disease. JAMA 243:557–564, 1980
Prantera C, Baiocchi G, Levenstein S, Livi U, Luzi C, Fanucci A: Clinical and laboratory parameters in Crohn's disease: Relation to disease activity, morphology and extent. Ital J Gastroenterol 13:24–27, 1981
Lloyd-Still JD, Green OC: A clinical scoring system for chronic inflammatory bowel disease in children. Dig Dis Sci 24:620–624, 1979
Faden H, Sutyla P, Ogra PL: Effect of viruses on luminol-dependent chemiluminescence of human neutrophils. Infect Immun 24:673–678, 1979
Faden H, Maciejewski N: Whole blood luminol-dependent chemiluminescence. J Reticuloendothel Soc 30:219–226, 1981
Ward M, Eastwood MA: The nitroblue tetrazolium test in Crohn's disease and ulcerative colitis. Digestion 14:179–183, 1976
Segal AW: Neutrophil dysfunction in Crohn's disease. Lancet 2:219–221, 1976
Binder V, Riis P: The leukocyte chemotactic function in patients with ulcerative colitis. Scand J Gastroenterol 12:141–144, 1977
Dow WF, Bootj CC, Brown DL: Evidence for complement-binding immune complexes in adult coeliac disease. Crohn's disease, and ulcerative colitis. Lancet 1:402–405, 1973
Jewell DT, MacLennan ICP, Truelove SC: Circulating immune complexes in ulcerative colitis and Crohn's disease. Gut 13:839, 1972
Kaul T, Faden H, Ogra PL: Effect of respiratory syncytial virus and virus antibody complexes on the oxidative metabolism of human neutrophils. Infect Immun 32:649–654, 1981
Author information
Authors and Affiliations
Additional information
This work was supported in part by public health grants AI-15939 from the National Institute of Allergy and Infectious Disease, HL-21829 from the National Institute of Heart, Lung and Blood Institute, and HD-15943 from the National Institute of Child Health and Human Development.
Rights and permissions
About this article
Cite this article
Faden, H., Rossi, T.M. Chemiluminescent response of neutrophils from patients with inflammatory bowel disease. Digest Dis Sci 30, 139–142 (1985). https://doi.org/10.1007/BF01308200
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01308200